Wall Street choppy after US regulators seek to pause rollout of Johnson & Johnson vaccine

Wall Street choppy after US regulators seek to pause rollout of Johnson & Johnson vaccine
The potential loss of the Johnson & Johnson Covid-19 vaccine is casting a shadow over many companies that are relying on ramped-up distribution to recover from the pandemic.